|
Volumn 22, Issue 3, 2000, Pages 193-196
|
Corticosteroids and cognitive function in humans: Methodological considerations
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CORTICOSTEROID;
DEXAMETHASONE;
PREDNISONE;
BODY WEIGHT DISORDER;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEMOGRAPHY;
DRUG EFFECT;
GROWTH RETARDATION;
HIPPOCAMPUS;
HUMAN;
INFECTION;
MENTAL DISEASE;
METHODOLOGY;
NOTE;
OSTEOPENIA;
PRIORITY JOURNAL;
STATISTICAL ANALYSIS;
STEROID THERAPY;
ANIMALS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BIAS (EPIDEMIOLOGY);
CHILD;
CLINICAL TRIALS;
COGNITION DISORDERS;
DEMOGRAPHY;
DEXAMETHASONE;
DOUBLE-BLIND METHOD;
EDUCATIONAL MEASUREMENT;
HIPPOCAMPUS;
HUMANS;
LEARNING;
LEARNING DISORDERS;
MEMORY;
MEMORY DISORDERS;
NEOPLASMS;
RECEPTORS, STEROID;
RESEARCH DESIGN;
RETROSPECTIVE STUDIES;
STRESS;
|
EID: 0034454665
PISSN: 01928562
EISSN: None
Source Type: Journal
DOI: 10.1097/00043426-200005000-00002 Document Type: Editorial |
Times cited : (3)
|
References (10)
|